银杏蜜环口服溶液联合尼可地尔对冠心病患者血清HsCRP、HCY、IMA、LP-PLA2水平的影响

目的:研究银杏蜜环口服溶液联合尼可地尔对冠心病患者血清超敏C反应蛋白(High-sensitivity C-reactive protein,Hs CRP)、同型半胱氨酸(Homocysteine,HCY)、缺血修饰白蛋白(Ischemia Modified Albumin,IMA)和脂蛋白相关磷脂酶A2(Lipoprotein-related phospholipase A2,Lp-PLA2)水平的影响。方法:选择2016年11月～2018年11月在我院全科医学科、急诊科收治的80例冠心病患者,根据就诊顺序,用抽签法随机分为两组,每组40例患者。对照组口服尼可地尔治疗,观察组采取银杏蜜环口服溶液联合尼可地尔治疗,两组均持续治疗2周。比较两组治疗前后的血清Hs CRP、HCY、IMA、LP-PLA2水平,左室舒张末径(left ventricular end-diastolic diameter,LVEDD)、心输出量(cardiac output,CO)和左室射血分数(left ventricular ejection fraction,LVEF)等心功能指标的变化。结果:治疗后,观察组的总有效率为92.50%(37/40),明显高于对照组[75.00%(30/40)](P0.05);两组治疗后的血清Hs CRP、HCY、IMA、LP-PLA2水平均较治疗前明显降低(P0.05),且观察组以上指标均明显低于对照组(P0.05);两组治疗后的LVEDD均较治疗前明显降低,而CO和LVEF均较治疗前明显升高(P均0.05),且观察组治疗后的LVEDD与对照组相比明显降低,而CO和LVEF显著升高(P0.05)。结论:银杏蜜环口服溶液联合尼可地尔治疗冠心病的疗效明显优于单独口服尼可地尔治疗,其机制可能与降低血清Hs CRP、HCY、IMA、LP-PLA2水平相关。     

大胡蜂蜂毒中多肽和蛋白质结构和功能的多样性

为证明大胡蜂Vespa magnifica(Smith)蜂毒具有较大的药用开发价值,本研究采用超高效液相色谱-质谱和电泳技术对其多肽和蛋白质的分布进行分析,发现其蛋白质的相对分子质量主要分布在17~45kDa范围内。蜂毒多肽类物质的相对分子质量呈"单峰"式分布,61%在500~3000Da范围内,为大胡蜂蜂毒中多肽含量最为丰富的部分。通过牛津杯法对蜂毒的抑菌活性进行研究,且以HepG2人肝癌细胞及B16黑色素瘤细胞为研究对象,用MTT法检测蜂毒的细胞毒性活性,证明其具有良好的抑菌作用和细胞毒活性,其结果与已报道的其他蜂类既有相似性又存在具体差异,展示了大胡蜂蜂毒的分子多样性,为后续该毒素的物质基础研究及药用价值开发提供参考。     

基于PIPE现象的质粒克隆位点序列设计与功能评价

分子克隆是现代生物学研究的核心技术之一,是基因工程、蛋白质工程中的重要手段。为提高分子克隆实验的操作效率,本研究设计并合成基于聚合酶引物不完全延伸（polymerase incomplete primer extension,PIPE）现象的质粒克隆位点序列。并以此为基础统一相关引物的设计方案,避免传统酶切--连接法中需针对不同载体MCS序列设计不同引物的缺点。该方案利用13 bp定长接头序列,在同一体系中使用2对引物、2种线性化模板同时扩增载体和插入片段,通过20个循环,在1次PCR过程中即合成可供转化使用的带缺口质粒产物。在NEB Q5酶系统中,利用此法将3种荧光素酶序列插入pET-15b及pET-21b(+)载体,均获得成功。且利用商品化感受态细胞（转化效率 > 5×108 cfu/μg）转化后所获得转化子数量均在300个以上,其中含插入片段的阳性克隆比例可达85%以上。基于本方案的设计及作用原理,可将其应用于10 kb以内载体和插入片段的快速重组。且具有通用性强、耗时少、阳性克隆得率高和成本低等优点,是传统DNA重组方法的有益补充,可作为各实验室的常规分子克隆手段之一。     

嗜热链球菌胞外多糖EPS333对酸乳品质的影响

本研究以酸乳为基质,通过测试酸乳酸化速率曲线、脱水收缩敏感性、持水力、水分迁移、质构及流变特性等参数,研究了嗜热链球菌胞外多糖与市场常规应用多糖对酸乳品质的影响。研究结果表明:嗜热链球菌胞外多糖EPS333在酸乳凝胶过程中较其他几种多糖能明显减缓酸化趋势,后熟及储藏阶段减少"自由水"含量,降低流动性,改善其流变特性。     

非洲猪瘟研究进展

非洲猪瘟是由非洲猪瘟病毒感染家猪或野猪后引发的一种急性、烈性传染病,主要通过病猪及其周围环境传播,蜱是中间宿主。1921年该病首次暴发于非洲肯尼亚,2018年8月传入我国,目前已有24个省级行政区发生疫情。非洲猪瘟病毒主要经呼吸道和消化道进入猪体内,感染靶细胞主要是单核-巨噬细胞,目前受体还不明确。非洲猪瘟病毒是单分子双链DNA病毒,长度为170~190kb,编码150~200种蛋白,包括多种免疫调控蛋白,可以抵抗机体免疫。非洲猪瘟病毒疫苗研究较多,包括灭活疫苗、减毒疫苗、亚单位疫苗和基因疫苗等,但迄今这些疫苗都不能保护家猪免受非洲猪瘟病毒感染。今后需要对非洲猪瘟病毒及其发病机制做详细系统的研究,为开发有效防治方案提供资料。     

Recombinant scFv antibodies against E protein and N protein of severe acute respiratory syndrome virus

Severe acute respiratory syndrome (SARS) brought aglobal outbreak in spring of 2003 [1–3], and more andmore attention has been paid on it when a new caseresurfaced in Singapore last September [4]. By the endof May in 2003, WHO reported a cumulative total of 8202infected cases with 725 deaths from 28 countries.Because of the high transmission and morality rate ofSARS, scientists in many countries have made theirefforts in studying SARS coronavirus (SARS-CoV)[5, 6]. Several genomes of…     

Molecular binding behavior of pyridine-2,6-dicarboxamide-bridged bis(beta-cyclodextrin) with oligopeptides: switchable molecular binding mode

Bridged bis(beta-cyclodextrin) 1 with a pyridine-2,6-dicarboxamide linker was synthesized, and its inclusion complexation behavior with some aliphatic oligopeptides was investigated in aqueous buffer solution of pH 2.0 and 7.2 at 25 degrees C by means of circular dichroism, fluorescence, and 2D NMR techniques. The results show that the resulting inclusion complexes of 1 with oligopeptides adopt a cooperative "cyclodextrin-guest-cyclodextrin" sandwich binding mode in a neutral media, but a "guest-linker-cyclodextrin" coinclusion binding mode in an acidic media. These switchable binding modes consequently rationalize the binding ability of bis(beta-cyclodextrin) 1 at different pH values; that is, 1 shows the stronger association with oligopeptides in a neutral media. Because of the simultaneous contributions of hydrophobic, hydrogen bond, and electrostatic interactions, bis(beta-cyclodextrin) 1 affords length-selectivity up to 4.7 for the Gly-Gly/Gly-Gly-Gly pair at pH 2.0 and sequence-selectivity up to 4.2 for the Gly-Leu/Leu-Gly pair at pH 7.2. These phenomena are discussed from the viewpoint of the size-fit concept and the multipoint recognitions between host and guest.     

Circadian rhythms of DNA synthesis in nasopharyngeal carcinoma cells

Nasopharyngeal carcinoma (NPC) occurs frequently in southern China. The circadian rhythm of DNA synthesis of a poorly differentiated NPC human cell line (CNE2) was investigated as an experimental prerequisite for designing chrono-chemotherapy schedules for patients with this disease. Twenty-two nude mice with BALB/c background were synchronized alternatively in 12 h of light and 12 h of darkness (LD12:12) for at least 3 wk prior to the transplantation of a CNE2 tumor fragment into each flank (area of ∼2×2 mm²). Ten days later, a tumor sample (area of ∼5 mm²) was obtained at 3, 9, 15, and 21 h after light onset (HALO) alternatively from different sites in each mouse. Single-cell suspensions were prepared and stained with propidium iodide. Cellular DNA content was measured with flow cytometry. Data were analyzed by ANOVA and cosinor methods. The average proportion of tumor cells in G₁, S or G₂-M phase varied according to circadian time with statistical significance. The maximum occurred at 9 HALO for G1, 2 HALO for S and 21 HALO for G₂-M phase cells. The approximate average distribution patterns of G₁ and G₂-M phases of cosine curve was 24 h. This was not the case for S-phase cells, which displayed a bimodal temporal pattern. Inter-individual variability in peak time was large, possibly due to relatively sparse sampling time. Nevertheless, no more than 6% of the time series displayed a maximum at 3 HALO for G₁, 21 HALO for S and 15 HALO for G₂-M. The cell cycle distribution of this human NPC cell line displayed circadian regulation following implantation into nude mice. The mechanisms involved in this rhythm and its relevance to the chrono-chemotherapy of patients deserve further investigation.     

罗布麻和大麻状罗布麻UV-B光受体UVR8基因的鉴定及表达分析

在植物响应紫外线B(ultraviolet-B,UV-B)的过程中,UV-B光受体UVR8(UV Resistance Locus 8)对植物的光形态建成和生长代谢等过程具有重要调控作用。为探究罗布麻属植物UV-B光受体信息,该研究通过罗布麻(Apocynum venetum)和大麻状罗布麻(A. cannabinum)全基因组数据进行UV-B光受体UVR8的筛选与生物信息学分析,同时利用转录组数据分析UV-B胁迫处理下的UVR8基因表达模式。结果表明:(1)罗布麻有6个UVR8基因,大麻状罗布麻有5个UVR8基因,前者分布在1、7、9和11号染色体上,后者分布在1、8和9号染色体上。(2)UVR8蛋白为亲水性稳定蛋白,定位在细胞核,不存在跨膜结构和信号肽,二级结构主要由延伸链、无规则卷曲、α-螺旋和β-转角构成。AvUVR8b和AcUVR8a蛋白三级结构与拟南芥UVR8(AtUVR8)最为类似,并且与小粒咖啡(CaUVR8)和伊德斯种咖啡(CeUVR8)的亲缘关系最近。同时发现罗布麻AvUVR8b和大麻状罗布麻AcUVR8a基因和蛋白结构与AtUVR8基因及蛋白高度相似。(3)当以一定剂量UV-B(17.52 kJ·m^-2·d^-1)处理两种罗布麻植株时,AvUVR8b和AcUVR8a的表达量上调。据此推测在响应UV-B时,AvUVR8b基因在罗布麻中起主要作用,AcUVR8a基因在大麻状罗布麻中起主要作用。(4)顺式作用元件分析结果表明,UVR8的表达受光照、温度、水分、氧气和激素等因素的调控。该研究将为进一步研究罗布麻属UVR8的基因功能奠定基础,同时为解析罗布麻属植物适应UV-B的分子机制提供线索。     

Intraductal Radiofrequency Ablation Followed by Locoregional Tumor Treatments for Treating Occluded Biliary Stents in Non-Resectable Malignant Biliary Obstruction: A Single-Institution Experience

Objectives

To determine the safety and feasibility of intraductal radiofrequency ablation (RFA) followed by locoregional tumor treatments in patients with non-resectable malignant biliary obstruction and stent re-occlusion.

Methods

Fourteen patients with malignant biliary obstruction and blocked metal stents were studied retrospectively. All had intraductal RFA followed by locoregional tumor treatments and were monitored clinically and radiologically. The practicality, safety, postoperative complications, jaundice remission, stent patency and survival time were analyzed.

Results

Combination treatment was successful for all patients. There were no severe complications during RFA or local treatments. All patients had stent patency restored, with a decline in serum bilirubin. Three patients had recurrent jaundice by 195, 237 and 357 days; two patients underwent repeat intraductal RFA; and one required an internal-external biliary drain. The average stent patency time was 234 days (range 187-544 days). With a median follow-up of 384 days (range 187-544 days), six patients were alive, while eight had died. There was no mortality at 30 days. The 3, 6, 12 and 18 month survival rates were 100%, 100%, 64.3% and 42.9%, respectively.

Conclusion

Intraductal RFA followed by locoregional tumor treatments for occluded metal stents is safe and practically feasible and potential increase stent patency and survival times.